Currently this Congress has reached capacity. Please contact to be included on the wait list. 


Breast cancer is the most common malignancy in women in the United States and is second only to lung cancer as a cause of cancer death. The treatment of breast cancer is rapidly evolving. Results from numerous clinical trials continue to expand new therapeutic options, treatment and risk reduction strategies, and diagnostic/prognostic tools. Healthcare professionals need to be educated on current and emerging scientific data to make evidence-based treatment decisions and to provide optimal care for patients with breast cancer.


The NCCN 2019 Congress Series™: Breast Cancer with Updates from the 2018 San Antonio Breast Cancer Symposium will provide expert insights on the current standard of care for patients with breast cancer and include the latest clinical research updates from the 2018 SABCS to assist clinicians in formulating breast cancer management strategies. 

This program has been approved for AMA PRA Category 1 Credit™ and ABIM MOC points for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.


Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!